Hematologists and nephrologists working together: moving forward with a new integrated care model for blood-related malignancies?
作者信息
Niscola Pasquale, Caravita Tommaso, Tatangelo Paola, Siniscalchi Agostina, de Fabritiis Paolo, Palumbo Roberto
机构信息
Hematology Unit, Department of Medical Specialties S. Eugenio Hospital (ASL Roma 2), Rome, Italy.
Nephrology Unit, Department of Medical Specialties S. Eugenio Hospital (ASL Roma 2), Rome, Italy.
出版信息
Blood Res. 2017 Sep;52(3):218-219. doi: 10.5045/br.2017.52.3.218. Epub 2017 Sep 25.
Abstract
摘要
相似文献
1
Hematologists and nephrologists working together: moving forward with a new integrated care model for blood-related malignancies?
Blood Res. 2017 Sep;52(3):218-219. doi: 10.5045/br.2017.52.3.218. Epub 2017 Sep 25.
2
Barriers to end-of-life discussions among hematologists: A qualitative study.
Palliat Med. 2018 May;32(5):1021-1029. doi: 10.1177/0269216318759862.
3
The need for training in palliative care for physicians in other specialties: Brazilian nephrologists empowerment (or appropriation) on renal supportive care.
Ann Palliat Med. 2018 Oct;7(Suppl 3):S176-S186. doi: 10.21037/apm.2018.07.07. Epub 2018 Aug 3.
4
Regional social system for specialized medical care in hematologic malignancies: a pilot study.
Rural Remote Health. 2009 Jul-Sep;9(3):1106. Epub 2009 Jul 28.
5
Nephrologists and Integrated Kidney Disease Care: Roles and Skills Essential for Nephrologists for Future Success.
Am J Kidney Dis. 2017 Jul;70(1):132-138. doi: 10.1053/j.ajkd.2017.02.372. Epub 2017 Apr 14.
6
Role of outpatient physicians in reporting of hematopoietic malignancies for statewide surveillance.
J Registry Manag. 2014 Fall;41(3):139-45.
7
Recovery opportunities, work-home conflict, and emotional exhaustion among hematologists and oncologists in private practice.
Psychol Health Med. 2017 Apr;22(4):462-473. doi: 10.1080/13548506.2016.1237666. Epub 2016 Sep 22.
8
Barriers to the Collaboration Between Hematologists and Palliative Care Teams on Relapse or Refractory Leukemia and Malignant Lymphoma Patients' Care: A Qualitative Study.
Am J Hosp Palliat Care. 2016 Dec;33(10):977-984. doi: 10.1177/1049909115611081. Epub 2015 Oct 22.
9
Nephrologists' management of patient medications in kidney transplantation: results of an online survey.
J Eval Clin Pract. 2015 Oct;21(5):879-85. doi: 10.1111/jep.12394. Epub 2015 Jun 17.
10
Achieving dialysis safety: The critical role of higher-functioning teams.
Semin Dial. 2019 May;32(3):266-273. doi: 10.1111/sdi.12778. Epub 2019 Mar 8.
引用本文的文献
1
Prostate cancer, chronic myelogenous leukemia and multiple myeloma in a single patient: a case report and review of the literature.
J Med Case Rep. 2023 Feb 5;17(1):35. doi: 10.1186/s13256-023-03753-z.
本文引用的文献
1
Baseline renal function as a prognostic indicator in patients with newly diagnosed diffuse large B-cell lymphoma.
Blood Res. 2016 Jun;51(2):113-21. doi: 10.5045/br.2016.51.2.113. Epub 2016 Jun 23.
2
How I treat acute myeloid leukemia presenting with preexisting comorbidities.
Blood. 2016 Jul 28;128(4):488-96. doi: 10.1182/blood-2016-01-635060. Epub 2016 May 27.
3
Eligibility of patients with renal impairment for Phase I trials: Time for a rethink?
Eur J Cancer. 2014 Nov;50(17):2893-6. doi: 10.1016/j.ejca.2014.09.001. Epub 2014 Sep 17.
4
The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?
Eur J Haematol. 2013 Oct;91(4):347-55. doi: 10.1111/ejh.12164. Epub 2013 Aug 17.
5
Onconephrology: the latest frontier in the war against kidney disease.
J Am Soc Nephrol. 2013 Jan;24(1):26-30. doi: 10.1681/ASN.2012070690. Epub 2012 Nov 8.
6
The Management of Membranous Glomerulopathy in Allogeneic Stem Cells Transplantation: Updated Literature.
Cardiovasc Hematol Agents Med Chem. 2013 Mar;11(1):67-76. doi: 10.2174/1871525711311010011.
7
Management of hematological malignancies in patients affected by renal failure.
Expert Rev Anticancer Ther. 2011 Mar;11(3):415-32. doi: 10.1586/era.11.2.
8
The use of major analgesics in patients with renal dysfunction.
Curr Drug Targets. 2010 Jun;11(6):752-8. doi: 10.2174/138945010791170879.
9
Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study.
Cancer. 2007 Sep 15;110(6):1376-84. doi: 10.1002/cncr.22904.
Zotero 插件